Related Experiment Video
Updated: Apr 1, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.4K
Reply to: Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation Therapy
Christopher H Crane1, Theodore S Hong1, Freddy E Escorcia1
1Christopher H. Crane, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Theodore S. Hong, MD, FASCO, Harvard Medical School, Boston, Massachusetts; Theodore S. Hong, MD, FASCO, Laboratory of Molecular Radiotherapy, National Institutes of Health, Bethesda, MD; Laura A. Dawson, MD, Department of Radiation Oncology, University of Toronto, Toronto, Canada, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Abstract
No abstract available in PubMed .

